Hopp til innhold
NHI.no
Annonse

Helvetesild, nervesmerter etter: Forebygging

Innhold i artikkelen

Det ser ut til at den beste måten å forebygge kroniske smerteplager på etter helvetesild er å gi god smertelindring i den akutte fasen. I en periode mente man at behandling med virushemmende midler i utslettperioden kunne forebygge senere smerteplager. Dette er etter hvert blitt studert grundig, og det er nå godt bevist at slik behandling ikke forebygger kroniske smerter.

Annonse

Det finnes to vaksiner mot helvetesild. Den ene med levende svekket vaksine (Zostavax) vil forhindre ca. 50 prosent av alle tilfellene av helvetesild og postherpetisk nevralgi, mens den andre (Shingrix) er en inaktivert vaksine som reduserer forekomsten av helvetesild og postherpetisk nevralgi med cirka 90 prosent. Begge vaksinene anbefales til personer over 50 år. Shingrix har i tillegg den fordelen at den kan brukes av personer over 18 år med nedsatt immunforsvar på grunn av sykdom eller immunhemmende behandling, eller som skal starte slik behandling.

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Postherpetisk nevralgi . Referanselisten for dette dokumentet vises nedenfor

  1. McElveen WA. Postherpetic neuralgia. Medscape, last updated Mar 06, 2018. emedicine.medscape.com
  2. Saguil A, Kane S, Mercado M, Lauters R. Herpes Zoster and Postherpetic Neuralgia: Prevention and Management. Am Fam Physician. 2017 Nov 15;96(10):656-663. PMID: 29431387. PubMed
  3. Johnson RW, Rice AS. Clinical practice. Postherpetic neuralgia. N Engl J Med. 2014 Oct 16;371(16):1526-33. doi: 10.1056/NEJMcp1403062 DOI
  4. Forbes HJ, Thomas SL, Smeeth L, et al. A systematic review and meta-analysis of risk factors for postherpetic neuralgia. Pain. 2016;157(1):30-54. PMID: 26218719 PubMed
  5. O'Connor KM, Paauw DS. Herpes zoster. Med Clin North Am. 2013;97(4):503–522, ix. PMID: 23809711. PubMed
  6. Dworkin RH, Gnann JW Jr, Oaklander AL, et al. Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain 2008; 9:S37. PubMed
  7. Pickering G, Leplege A. Herpes zoster pain, postherpetic neuralgia, and quality of life in the elderly. Pain Pract. 2011 Jul-Aug;11(4):397-402. Epub 2010 Dec 29. PMID: 21199312. PubMed
  8. Navez ML, Monella C, Bösl I, Sommer D, Delorme C. 5% Lidocaine Medicated Plaster for the Treatment of Postherpetic Neuralgia: A Review of the Clinical Safety and Tolerability. Pain Ther. 2015 Jun;4(1):1-15. pmid: 25896574. PubMed
  9. Slapø GD, Schjøtt J. Medikamentell behandling av nevropatisk smerte. Tidsskr Nor Legeforen 2013; 133: 971-3. Tidsskrift for Den norske legeforening
  10. Liu X, Wei L, Zeng Q, et al. The Treatment of Topical Drugs for Postherpetic Neuralgia: A Network Meta-Analysis. Pain Physician 2020; 23: 541-51. PMID: 33185370 PubMed
  11. Mou J, Paillard F, Turnbull B, et al. Qutenza (Capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients. Clin J Pain 2013 Jun 11. PMID: 23765045. PubMed
  12. Moore RA, Wiffen PJ, Derry S, Toelle T, Rice AS. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2014; 4: CD007938. doi:10.1002/14651858.CD007938.pub3 DOI
  13. Sang CN, Sathyanarayana R, Sweeney M. Gastroretentive gabapentin (G-GR) formulation reduces intensity of pain associated with postherpetic neuralgia (PHN). Clin J Pain 2012, Jul 13. pmid:22801243. PubMed
  14. Fan H, Yu W, Zhang Q, et al. Efficacy and safety of gabapentin 1800 mg treatment for post-herpetic neuralgia: a meta-analysis of randomized controlled trials. J Clin Pharm Ther. 2014;39(4):334-42. doi: 10.1111/jcpt.12167 DOI
  15. Freynhagen R, Strojek K, Griesing T, Whalen E, Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 2005; 115: 254-63. PubMed
  16. Wiffen PJ, Derry S, Moore RA, et al. Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2013 ;11:CD010567. doi: 10.1002/14651858.CD010567.pub2 DOI
  17. Zin CS, Nissen LM, Smith MT, et al. An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy. CNS Drugs 2008; 22: 417-42. PubMed
  18. McNicol ED, Midbari A, Eisenberg E. Opioids for neuropathic pain. Cochrane Database Syst Rev 2013; 8: CD006146. doi: 10.1002/14651858.CD006146.pub2 DOI
  19. Apalla Z, Sotiriou E, Lallas A, et al. Botulinum toxin A in postherpetic neuralgia: A parallel, randomized, double-blind, single-dose, placebo-controlled trial. Clin J Pain 2013. pmid:23370074 PubMed
  20. Wu CY, Lin HC, Chen SF, et al. Efficacy of Pulsed Radiofrequency in Herpetic Neuralgia: A Meta-Analysis of Randomized Controlled Trials. Clin J Pain. 2020 Nov;36(11):887-895. PMID: 32701526 PubMed
  21. Kotani N, Kushikata T, Hashimoto H, et al. . Intrathecal methylprednisolone for intractable postherpetic neuralgia.. N Engl J Med 2000; 343: 1514-9. PubMed
  22. Chen N, Li Q, Yang J, et al. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2014;2:CD006866. PMID: 24500927 PubMed
  23. Jiang X, Li Y, Chen N, et al. Corticosteroids for preventing postherpetic neuralgia. Cochrane Database Syst Rev 2023; 12: CD005582. pmid:38050854 PubMed
  24. Gagliardi AMZ, Andriolo BNG, Torloni MR, et al. Vaccines for preventing herpes zoster in older adults. Cochrane Database of Systematic Reviews 2019, Issue 11. The Cochrane Library
  25. Johnson RW, Bouhassira D, Kassianos G, Leplège A, Schmader KE, Weinke T. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med. 2010 Jun 21;8:37. doi: 10.1186/1741-7015-8-37. PMID: 20565946 PubMed
  26. Yawn BP, Gilden D. The global epidemiology of herpes zoster. Neurology. 2013 Sep 3;81(10):928-30. PMID: 23999562 PubMed
  27. Massengill JS, Kittredge JL. Practical considerations in the pharmacological treatment of postherpetic neuralgia for the primary care provider. J Pain Res. 2014;7:125–132. PMID: 24648752. PubMed
Annonse
Annonse